AUTONOMIX MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 0.00 shares.
- AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares.
- AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares.
- AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-13 | 0.00 shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | 0.00 shares 10-K · filed 2025-05-29 |
| 2024-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | 0.00 shares derived: sum of 4 quarters · filed 2025-02-13 |
| 2024-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | 0.00 shares 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |